Home » Topics » BioWorld Science

BioWorld Science
RSS

Mainline Biosciences submits pre-IND meeting information package for MLB-1707

May 11, 2018

Promising in vivo results for EP-055, a potential nonhormonal male contraceptive

May 11, 2018

First patient dosed in the phase I/II trial of KB-103

May 11, 2018

EVOLVE-MS-1 trial shows ALKS-8700 effects in patients with relapsing remitting multiple sclerosis

May 11, 2018

SPRINT-MS trial: phase II results of ibudilast treatment in progressive multiple sclerosis

May 11, 2018

Shionogi recaps progress of fourth quarter of fiscal 2017

May 11, 2018

Intrommune Therapeutics launches financing campaign to support development of INT-301

May 11, 2018

CFDA clears HG-146 to enter clinical trials for multiple myeloma

May 11, 2018

LogicBio Therapeutics begins program for genome-editing therapy for methylmalonic acidemia

May 11, 2018

Gilead studies GS-9688 in virally suppressed patients with chronic HBV infection

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...